SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing. (7th October 2021)
- Record Type:
- Journal Article
- Title:
- SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing. (7th October 2021)
- Main Title:
- SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing
- Authors:
- Srivatsan, Sanjay
Heidl, Sarah
Pfau, Brian
Martin, Beth K
Han, Peter D
Zhong, Weizhi
van Raay, Katrina
McDermot, Evan
Opsahl, Jordan
Gamboa, Luis
Smith, Nahum
Truong, Melissa
Cho, Shari
Barrow, Kaitlyn A
Rich, Lucille M
Stone, Jeremy
Wolf, Caitlin R
McCulloch, Denise J
Kim, Ashley E
Brandstetter, Elisabeth
Sohlberg, Sarah L
Ilcisin, Misja
Geyer, Rachel E
Chen, Wei
Gehring, Jase
Kosuri, Sriram
Bedford, Trevor
Rieder, Mark J
Nickerson, Deborah A
Chu, Helen Y
Konnick, Eric Q
Debley, Jason S
Shendure, Jay
Lockwood, Christina M
Starita, Lea M
… (more) - Abstract:
- Abstract: Background: The urgent need for massively scaled clinical testing for SARS-CoV-2, along with global shortages of critical reagents and supplies, has necessitated development of streamlined laboratory testing protocols. Conventional nucleic acid testing for SARS-CoV-2 involves collection of a clinical specimen with a nasopharyngeal swab in transport medium, nucleic acid extraction, and quantitative reverse-transcription PCR (RT–qPCR). As testing has scaled across the world, the global supply chain has buckled, rendering testing reagents and materials scarce. To address shortages, we developed SwabExpress, an end-to-end protocol developed to employ mass produced anterior nares swabs and bypass the requirement for transport media and nucleic acid extraction. Methods: We evaluated anterior nares swabs, transported dry and eluted in low-TE buffer as a direct-to-RT–qPCR alternative to extraction-dependent viral transport media. We validated our protocol of using heat treatment for viral inactivation and added a proteinase K digestion step to reduce amplification interference. We tested this protocol across archived and prospectively collected swab specimens to fine-tune test performance. Results: After optimization, SwabExpress has a low limit of detection at 2–4 molecules/µL, 100% sensitivity, and 99.4% specificity when compared side by side with a traditional RT–qPCR protocol employing extraction. On real-world specimens, SwabExpress outperforms an automated extractionAbstract: Background: The urgent need for massively scaled clinical testing for SARS-CoV-2, along with global shortages of critical reagents and supplies, has necessitated development of streamlined laboratory testing protocols. Conventional nucleic acid testing for SARS-CoV-2 involves collection of a clinical specimen with a nasopharyngeal swab in transport medium, nucleic acid extraction, and quantitative reverse-transcription PCR (RT–qPCR). As testing has scaled across the world, the global supply chain has buckled, rendering testing reagents and materials scarce. To address shortages, we developed SwabExpress, an end-to-end protocol developed to employ mass produced anterior nares swabs and bypass the requirement for transport media and nucleic acid extraction. Methods: We evaluated anterior nares swabs, transported dry and eluted in low-TE buffer as a direct-to-RT–qPCR alternative to extraction-dependent viral transport media. We validated our protocol of using heat treatment for viral inactivation and added a proteinase K digestion step to reduce amplification interference. We tested this protocol across archived and prospectively collected swab specimens to fine-tune test performance. Results: After optimization, SwabExpress has a low limit of detection at 2–4 molecules/µL, 100% sensitivity, and 99.4% specificity when compared side by side with a traditional RT–qPCR protocol employing extraction. On real-world specimens, SwabExpress outperforms an automated extraction system while simultaneously reducing cost and hands-on time. Conclusion: SwabExpress is a simplified workflow that facilitates scaled testing for COVID-19 without sacrificing test performance. It may serve as a template for the simplification of PCR-based clinical laboratory tests, particularly in times of critical shortages during pandemics. … (more)
- Is Part Of:
- Clinical chemistry. Volume 68:Number 1(2022)
- Journal:
- Clinical chemistry
- Issue:
- Volume 68:Number 1(2022)
- Issue Display:
- Volume 68, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 68
- Issue:
- 1
- Issue Sort Value:
- 2022-0068-0001-0000
- Page Start:
- 143
- Page End:
- 152
- Publication Date:
- 2021-10-07
- Subjects:
- Clinical chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Biochimie -- Périodiques
Diagnostics biologiques -- Périodiques
Biochemistry
Clinical chemistry
Pharmaceutical chemistry
Biochemistry
Laboratory Techniques and Procedures
Klinische chemie
Periodicals
616.075605 - Journal URLs:
- http://www.oxfordjournals.org/ ↗
https://academic.oup.com/clinchem ↗
http://catalog.hathitrust.org/api/volumes/oclc/1554929.html ↗
http://www.clinchem.org/ ↗ - DOI:
- 10.1093/clinchem/hvab132 ↗
- Languages:
- English
- ISSNs:
- 0009-9147
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25211.xml